Robert Sokolic

Center for Biologics Evaluation and Research

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency”.

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency

New England Journal of Medicine(2021)10.1056/nejmoa2027675

N/A

5.1DataRank · unranked

219 citations

Claire Booth, Kit L. Shaw, Jinhua Xu‐Bayford, Elizabeth Garabedian, Valentina Trevisan +48 more

Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency

Blood(2021)10.1182/blood.2020010260

N/A

2.0DataRank · unranked

48 citations

Omar Habib, Kit L. Shaw, Elizabeth Garabedian, Denise A. Carbonaro-Sarracino, Dayna Terrazas +31 more

Severe combined immunodeficiency: improved survival leading to detection of underlying liver disease

BMC Gastroenterology(2023)10.1186/s12876-023-02782-8

N/A

0DataRank · unranked

0 citations

Nehna Abdul Majeed, Elizabeth Garabedian, Jamie Marko, David E. Kleiner, Robert Sokolic +5 more

FDA Approval Summary: Idecabtagene Vicleucel for the Treatment of Triple-Class–Exposed, Relapsed or Refractory Multiple Myeloma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-4181

N/A

0DataRank · unranked

8 citations

Xue Lin, Zhenzhen Xu, Bindu Kanapuru, Marc R. Theoret, Robert Sokolic +2 more